rs139633545

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2

The NM_002294.3(LAMP2):ā€‹c.1142T>Cā€‹(p.Val381Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000546 in 1,209,735 control chromosomes in the GnomAD database, including 1 homozygotes. There are 21 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00023 ( 0 hom., 7 hem., cov: 23)
Exomes š‘“: 0.000036 ( 1 hom. 14 hem. )

Consequence

LAMP2
NM_002294.3 missense

Scores

7
8
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 8.51
Variant links:
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP6
Variant X-120431414-A-G is Benign according to our data. Variant chrX-120431414-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 180882.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=2, Uncertain_significance=2}. Variant chrX-120431414-A-G is described in Lovd as [Benign]. Variant chrX-120431414-A-G is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 7 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LAMP2NM_002294.3 linkuse as main transcriptc.1142T>C p.Val381Ala missense_variant 9/9 ENST00000200639.9 NP_002285.1
LAMP2NM_001122606.1 linkuse as main transcriptc.1094-2788T>C intron_variant NP_001116078.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LAMP2ENST00000200639.9 linkuse as main transcriptc.1142T>C p.Val381Ala missense_variant 9/91 NM_002294.3 ENSP00000200639 P3P13473-1
LAMP2ENST00000434600.6 linkuse as main transcriptc.1094-2788T>C intron_variant 1 ENSP00000408411 A1P13473-3
LAMP2ENST00000706600.1 linkuse as main transcriptc.*1001T>C 3_prime_UTR_variant 9/9 ENSP00000516464
LAMP2ENST00000486593.5 linkuse as main transcriptc.*127T>C 3_prime_UTR_variant, NMD_transcript_variant 7/75 ENSP00000431526

Frequencies

GnomAD3 genomes
AF:
0.000232
AC:
26
AN:
112272
Hom.:
0
Cov.:
23
AF XY:
0.000203
AC XY:
7
AN XY:
34446
show subpopulations
Gnomad AFR
AF:
0.000711
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000555
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00133
GnomAD3 exomes
AF:
0.000116
AC:
21
AN:
181255
Hom.:
0
AF XY:
0.000119
AC XY:
8
AN XY:
67135
show subpopulations
Gnomad AFR exome
AF:
0.00106
Gnomad AMR exome
AF:
0.0000730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000361
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000364
AC:
40
AN:
1097463
Hom.:
1
Cov.:
29
AF XY:
0.0000386
AC XY:
14
AN XY:
362985
show subpopulations
Gnomad4 AFR exome
AF:
0.000265
Gnomad4 AMR exome
AF:
0.0000568
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000132
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000586
GnomAD4 genome
AF:
0.000232
AC:
26
AN:
112272
Hom.:
0
Cov.:
23
AF XY:
0.000203
AC XY:
7
AN XY:
34446
show subpopulations
Gnomad4 AFR
AF:
0.000711
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000555
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00133
Alfa
AF:
0.000125
Hom.:
3
Bravo
AF:
0.000253
ESP6500AA
AF:
0.00156
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000165
AC:
20

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 23, 2015Variant classified as Uncertain Significance - Favor Benign. The p.Val381Ala var iant in LAMP2 has not been previously reported in individuals with cardiomyopath y or Danon disease, but has been identified in 0.1% (11/8513) African chromosome s, including 3 hemizygotes, by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs139633545). Computational prediction tools and co nservation analysis suggest that this variant may impact the protein, though thi s information is not predictive enough to determine pathogenicity. In summary, w hile the clinical significance of the p.Val381Ala variant is uncertain, its freq uency and presence in multiple hemizygous control individuals suggests that it is more likely to be benign. -
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioMay 11, 2021- -
Danon disease Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 11, 2024- -
LAMP2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 17, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxOct 02, 2020- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 18, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
CardioboostCm
Benign
0.062
BayesDel_addAF
Uncertain
0.081
D
BayesDel_noAF
Pathogenic
0.29
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.88
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Uncertain
0.56
D
MetaSVM
Uncertain
-0.058
T
MutationAssessor
Pathogenic
3.1
M
MutationTaster
Benign
1.0
D;D;D
PROVEAN
Uncertain
-3.9
D
REVEL
Pathogenic
0.65
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.73
MVP
0.96
ClinPred
0.22
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139633545; hg19: chrX-119565269; API